My watch list
my.chemeurope.com  
Login  

10-14-2009: The Catalysts Business Line of Evonik Industries and the Swiss-based company Solvias AG have renewed their license agreement for vanadium-doped precious metal powder catalysts for the hydrogenation of nitro compounds. Evonik will continue to market these catalysts, which were developed by Solvias, on an exclusive basis but the underlying business model has been greatly simplified effective October 1, 2009. “Anyone purchasing these catalysts from Evonik now automatically acquires the right to utilize the technology,” explains Dr. Jürgen Krauter, head of Marketing at Evonik’s Catalysts Business Line. “Additional license agreements and fees will no longer be necessary.”

Solvias will continue to use this technology for customized process development and optimization. This Swiss company thus retains access to the entire platform of technologies for hydrogenation of nitro groups with vanadium-based catalysts. Alongside the ready-to-use vanadium-doped catalysts marketed by Evonik, this includes in-situ variants comprising platinum catalysts to which a vanadium salt is added during the reaction.

Contact / Request information

Request further information free of charge:

Watchlist

This is where you can add this news to your personal favourites

More about Solvias
Contact
Solvias AG
Römerpark 2
4303 Kaiseraugst
SWITZERLAND
Phone
+41 61 845 60 00
Fax
+41 61 845 69 00
  • News

    Dr. Syuzanna R. Harutyunyan wins Solvias Ligand Contest

    The jury of the annual Solvias Ligand Contest awarded the 2011 prize to Dr. Syuzanna R. Harutyunyan, Assistant Professor in Synthetic Organic Chemistry at the University of Groningen. The Award Ceremony and presentation of the prize-winning contribution took place during the 10th Science Da ... more

    Solvias and RohnerChem announce partnership for custom research and manufacturing services

    Solvias and RohnerChem announced a partnership for custom research and manufacturing services. The preferred but non-exclusive partnership closes the chain of services from route scouting through to commercial manufacturing. Customers will benefit from the synergy of Solvias’ expertise in c ... more

    Solvias opens new Corporate Location

    Just in time for the New Year, the company relocated from Basel to Kaiseraugst. The new laboratories offer more space to provide the pharmaceutical and biopharmaceutical industry with the spectrum of services that includes analysis of large and small molecules, solid-state development, ... more

  • Companies

    Solvias AG

    Solvias is a privately held company located in Kaiseraugst/Switzerland. With over 300 highly qualified employees, Solvias supports the research and development of new drug substances and the optimization of manufacturing processes for pharmaceutical, biotechnology and life science companies ... more

More about Evonik
Most read news
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE